Study of Human Botulism Immunoglobulin in Infants With Botulism

Summary

OBJECTIVES: I. Determine the safety of human botulism immune globulin (BIG) in patients with infant botulism by monitoring side effects (e.g., rash, fever, hypotension, and anaphylaxis). II. Assess the efficacy of BIG in these patients by monitoring disease severity, incidence of complications (respiratory arrest, aspiration, pneumonia, etc.), and length of hospital stay.

Timeline

Start

1998-01

Primary completion

—

Completion

1998-06

Drugs

Indications